Approval · Notice of Compliance 22678 · 2019
FINACEA: Notice of Compliance 22678
Issued September 18, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22678
- Date
- September 18, 2019
- Company
- Leo Pharma IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Reason
- Change in product ownership. update to the product labels according to plain language labelling standards
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FINACEA | 02270811 | Marketed |
Medicinal ingredients
- AZELAIC ACID 15 PER